2.47  -0.09 (-3.52%)		12-15 15:59
Open: 2.55 High: 2.615 Volume: 148,529		Pre. Close: 2.56 Low: 2.36 Market Cap: 15(M)

Short term
Mid term
Targets	6-month :	4.79	1-year :	6.04
Resists	First :	4.1	Second :	5.17
Pivot price	2.77
Supports	First :	2.35	Second :	1.96
MAs	MA(5) :	2.69	MA(20) :	2.77
	MA(100) :	5.66	MA(250) :	0
MACD	MACD :	-0.5	Signal :	-0.6
%K %D	K(14,3) :	13.7	D(3) :	21.7
RSI	RSI(14): 34.1
52-week	High :	18.96	Low :	2.35

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ RBOT ] has closed above bottom band by 15.9%. Bollinger Bands are 67.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	2.62 - 2.64	2.64 - 2.65
Low:	2.32 - 2.34	2.34 - 2.36
Close:	2.44 - 2.47	2.47 - 2.49

Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Sat, 13 Dec 2025
How Vicarious Surgical Inc. Class A (RBOT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Thu, 04 Dec 2025
Khalifa Sammy, Vicarious Surgical CTO, sells $709 in RBOT stock - Investing.com

Wed, 03 Dec 2025
Vicarious Surgical (NYSE: RBOT) Trims 2025 Cash Burn by $5M, Updates Board - Stock Titan

Fri, 21 Nov 2025
Sachs Adam David, president at Vicarious Surgical, sells $2215 in stock - Investing.com

Wed, 12 Nov 2025
Vicarious Surgical is moving surgical robot timeline back again - MassDevice

Wed, 08 Oct 2025
$5.9M Proceeds: Vicarious Surgical Prices Registered Direct Offering; 1.15M Shares to Close Oct 9 - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Devices
Shares Out	6 (M)
Shares Float	4 (M)
Held by Insiders	19.5 (%)
Held by Institutions	27.1 (%)
Shares Short	151 (K)
Shares Short P.Month	183 (K)

EPS	-9.03
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	2.35
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-63.4 %
Return on Equity (ttm)	-149 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-8.83
Qtrly Earnings Growth	0 %
Operating Cash Flow	-48 (M)
Levered Free Cash Flow	-28 (M)

PE Ratio	-0.28
PEG Ratio	0
Price to Book value	1.04
Price to Sales	0
Price to Cash Flow	-0.32

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.